Mónica Martínez-Cengotitabengoa-rekin lankidetzan egindako argitalpenak (10)

2018

  1. The complex association between the antioxidant defense system and clinical status in early psychosis

    PLoS ONE, Vol. 13, Núm. 4

2016

  1. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

2015

  1. Pro-/antiinflammatory dysregulation in early psychosis: Results from a 1-year follow-Up study

    International Journal of Neuropsychopharmacology, Vol. 18, Núm. 2, pp. 1-10

2014

  1. Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

    Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29

  2. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia

    Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387

2012

  1. Antioxidant defense system and family environment in adolescents with family history of psychosis

    BMC Psychiatry, Vol. 12

  2. Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes

    Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 66-72

  3. Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study

    Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 58-65

2011

  1. Adverse drug events in older adults: Development of a predictive model

    Journal of the American Geriatrics Society

  2. Reduced antioxidant defense in early onset first-episode psychosis: A case-control study

    BMC Psychiatry, Vol. 11